title: 2'3'Cyclic nucleotide 3'phosphodiesterase immunohistochemistry shows an impairment on myelin compaction in hypothyroid rats.
abstract: The effects of hypothyroidism on oligodendroglial differentiation and myelination are for the first time studied by immunohistochemical localization of an early oligodendroglial marker, the 2'3'cyclic nucleotide 3'phosphodiesterase (E.C. 3.1.4.37-CNPase), in developing rats. Two groups received methimazol; one during gestation (H) and another postnatally (PN). One H sub-group received thyroxine after birth (T). We observed a delay in CNPase expression followed by a decrease in the number of CNPase immunoreactive fibers in both H and PN groups. The T sub-group was not different from controls. Furthermore, the immunoreactive fibers, in mature hypothyroid animals, showed a continuous pattern of staining in contrast with a discontinuous one in controls. Myelinogenesis is a highly regulated timed event. CNPase links myelin related proteins to the cytoskeleton also interacting with membrane lipids during extension and wrapping of the oligodendroglial process around the axon (ensheathment phase). In mature myelinated fiber the CNPase is absent from compact myelin sheath, being located only in the inner and outer loops and in paranodal loops. Thus, our data suggest a disorder in myelin compaction and point once more to the post-natal period as critical for the mechanisms that are thyroid hormone regulated in myelinogenesis.
authors.affiliation: Depto. Farmacologia e Psicobiologia, Instituto de Biologia Roberto Alcântara Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil. penha@uerj.br
authors.forename: P C
authors.initials: PC
authors.lastname: Barradas
authors.forename: A S
authors.initials: AS
authors.lastname: Ferraz
authors.forename: A A
authors.initials: AA
authors.lastname: Ferreira
authors.forename: R P
authors.initials: RP
authors.lastname: Daumas
authors.forename: E G
authors.initials: EG
authors.lastname: Moura
mesh_terms: D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000032:analysis*; D000818:Animals; D013956:Antithyroid Agents; D001921:Brain / Q000002:abnormalities* / Q000201:enzymology* / Q000473:pathology; D003409:Congenital Hypothyroidism; D005260:Female; D007037:Hypothyroidism / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D007150:Immunohistochemistry; D008713:Methimazole; D009186:Myelin Sheath / Q000201:enzymology* / Q000473:pathology; D009836:Oligodendroglia / Q000201:enzymology / Q000473:pathology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D017208:Rats, Wistar; D013974:Thyroxine / Q000494:pharmacology
chemical_list: D013956:Antithyroid Agents; D008713:Methimazole; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases; D013974:Thyroxine